Sance Laboratories Private Limited
Indian Pharmaceutical Exporter ยท Antibiotics Specialist ยท $6.5M Total Trade ยท DGFT Verified
Sance Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $6.5M across 4 products in 2 therapeutic categories. Based on 177 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Cephalexin ($3.6M), Cefixime ($2.4M), Cefpodoxime ($303.5K).
Sance Laboratories Private Limited โ Export Portfolio & Destination Treemap

Who is Sance Laboratories Private Limited? โ Company Overview & Market Position
Sance Laboratories Private Limited, established on September 20, 2001, is a privately held Indian pharmaceutical company specializing in the manufacturing and export of cephalosporin antibiotic formulations. The company is headquartered in Kottayam, Kerala, India, with its registered office located at VI/51B, Elappunkal Junction, Kozhuvanal P.O., Pala, Kottayam District, Kerala 686573.
The company is classified as a private limited entity under the Corporate Identification Number (CIN) U24231KL2001PTC014957. As of the latest available financial data, Sance Laboratories has an authorized share capital of โน4,00,00,000 and a paid-up capital of โน3,95,99,970. In the fiscal year ending March 31, 2025, the company reported a 15.98% increase in total revenue, a 12.85% rise in profit, and a 17.51% growth in net worth, indicating robust financial health.
Sance Laboratories employs a dedicated workforce across various departments, including Quality Assurance, Production, Quality Control, Formulation & Development, Engineering, Finance, and Administration. The company's website, sancepharma.com, provides further insights into its operations and product offerings.